Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Bojke

Showing results (81-90 of 84) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 84 results.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Health Technology Assessment (Winchester, England)|November 11, 2020
Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCTRuth Gilbert, Michaela Brown, Rita Faria, et al.
Bulletin of the World Health Organization|April 2, 2026
Valuing reductions in the risk of death in benefit-cost analyses of environment- and climate-health actionsFrank Pega, Natalie C Momen, Samuel A Agyemang, et al.
Pageof 9

Showing results (81-90 of 84) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 84 results.
Applied Health Economics and Health Policy|November 30, 2024
Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Applied Health Economics and Health Policy|June 2, 2025
Correction: Assessing the Value of New Antimicrobials: Evaluations of Cefiderocol and Ceftazidime-Avibactam to Inform Delinked Payments by the NHS in EnglandBeth Woods, Ben Kearns, Laetitia Schmitt, et al.
Health Technology Assessment (Winchester, England)|November 11, 2020
Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCTRuth Gilbert, Michaela Brown, Rita Faria, et al.
Bulletin of the World Health Organization|April 2, 2026
Valuing reductions in the risk of death in benefit-cost analyses of environment- and climate-health actionsFrank Pega, Natalie C Momen, Samuel A Agyemang, et al.
Pageof 9